Overview

OncoLize develops injectable drug depots to treat rare and deadly tumour diseases. Using thin needles or catheters, we localize the small drug depot inside the solid tumour. While graudally eroding away, the depot slowly releases a range of well-known drugs inside the tumour. This is done at much higher concentrations than ever possible via oral medication or intravenous injections, yet the total load of the drug is limited to the volume of the tumour. The benefits are relevant: better treatment options for the patient and the doctor, with far less side-effects, and at much lower costs. We will start with GBM-tumours in the brain, and add pancreatric, prostate and urinary tract tumours to our portfolio as we develop a range of depots containing different Chemo-drugs. Our website will go live end of November.